PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.220
+0.010 (0.83%)
At close: Dec 5, 2025, 4:00 PM EST
1.150
-0.070 (-5.74%)
After-hours: Dec 5, 2025, 7:59 PM EST
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $8.29 million as of December 5, 2025. Its market cap has decreased by -41.61% in one year.
Market Cap
8.29M
Enterprise Value
-5.15M
1-Year Change
-41.61%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since January 2, 2013, PharmaCyte Biotech's market cap has decreased from $17.00M to $8.29M, a decrease of -51.23%. That is a compound annual growth rate of -5.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.30M | -23.85% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 219.75% |
| Dec 31, 2020 | 16.20M | -72.16% |
| Dec 31, 2019 | 58.20M | 35.03% |
| Dec 31, 2018 | 43.10M | -23.17% |
| Dec 29, 2017 | 56.10M | -57.11% |
| Dec 30, 2016 | 130.80M | 266.39% |
| Dec 31, 2015 | 35.70M | -72.56% |
| Dec 31, 2014 | 130.10M | 108.16% |
| Dec 31, 2013 | 62.50M | 267.65% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |